Clinical Trials Directory

Trials / Unknown

UnknownNCT05268913

Towards Early Detection of Breast Cancer in High Risk Population

Robust EArly Detection of bReast Cancer in hIgh riSK Premenopausal Population Using Novel Lipid Based Imaging Methods

Status
Unknown
Phase
Study type
Observational
Enrollment
120 (estimated)
Sponsor
University of Aberdeen · Academic / Other
Sex
Female
Age
18 Years – 55 Years
Healthy volunteers
Accepted

Summary

Breast cancer is a major and growing health challenge, and the leading cause of cancer in women. As population obesity rates increase, the number of new breast cancer diagnosis continues to rise. Despite treatment advances, breast cancer remains an important cause of premature mortality, taking women in the prime of life. Although underlying susceptibility caused by mutation in the genes including BRCA1/2 is increasingly identified, current pre-symptomatic screening for the general population and those at high genetic risk remains sub-optimal, with high false negative and positive rates. Alteration of breast lipid composition has been observed by us and others in patients with breast cancer and is thought to precede onset. We have developed and tested a novel method to allow a standard 3T MRI scanner to perform quantitative 3D mapping of specific lipid molecules in the breast. We will investigate if this method can detect very early breast cancers, and compare the amount and spread of lipid composition in breast tissue of premenopausal women with very high genetic risk of breast cancer, women with breast cancer and women with obesity.

Conditions

Interventions

TypeNameDescription
DIAGNOSTIC_TESTMRI scanParticipants will undertake a magnetic resonance imaging scan.
BIOLOGICALBlood testParticipants will undertake a fasting blood test.

Timeline

Start date
2022-03-01
Primary completion
2024-05-01
Completion
2024-05-01
First posted
2022-03-07
Last updated
2022-03-07

Locations

1 site across 1 country: United Kingdom

Source: ClinicalTrials.gov record NCT05268913. Inclusion in this directory is not an endorsement.